{"id":"NCT00449956","sponsor":"Merck Sharp & Dohme LLC","briefTitle":"MK0507A Clinical Study in Patients With Glaucoma and Ocular Hypertension (0507A-149)(COMPLETED)","officialTitle":"Multicenter, Double-Blind, Active Comparator-controlled Study to Evaluate the Safety and Efficacy of MK0507A in Patients With Glaucoma and Ocular Hypertension Who Are Inadequately Controlled on Beta-Blockers","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2007-03-12","primaryCompletion":"2008-02-16","completion":"2008-02-16","firstPosted":"2007-03-21","resultsPosted":"2009-05-29","lastUpdate":"2017-06-20"},"enrollment":474,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Glaucoma"],"interventions":[{"type":"DRUG","name":"dorzolamide hydrochloride (+) timolol maleate","otherNames":[]},{"type":"DRUG","name":"Comparator: timolol maleate","otherNames":[]},{"type":"DRUG","name":"Comparator: dorzolamide hydrochloride","otherNames":[]}],"arms":[{"label":"1","type":"EXPERIMENTAL"},{"label":"2","type":"ACTIVE_COMPARATOR"},{"label":"3","type":"ACTIVE_COMPARATOR"}],"summary":"The clinical study compares safety and efficacy of MK0507A (dorzolamide 1.0% / timolol 0.5%) with 1) timolol 0.5% and with 2) concomitant therapy with dorzolamide 1.0% / timolol 0.5% in patients with glaucoma and ocular hypertension.","primaryOutcome":{"measure":"Change in Intraocular Pressure (IOP) From Baseline at 8 Weeks","timeFrame":"8 weeks","effectByArm":[{"arm":"MK0507A (Dorzolamide 1.0% / Timolol 0.5% Combination)","deltaMin":-2.5,"sd":null},{"arm":"Timolol 0.5%","deltaMin":-1.82,"sd":null},{"arm":"Concomitant (Dorzolamide 1.0% / Timolol 0.5%)","deltaMin":-2.78,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG002","p":null}]},"eligibility":{"minAge":"20 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":1,"exclusionCount":2},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["21735753"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":2},"commonTop":["Instillation site irritation","Nasopharyngitis","Glucose urine present","Alanine aminotransferase increased","Corneal epithelium defect"]}}